Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Steroid implant in anterior chamber of an aphakic vitrectomized eye.

× No keyword cloud information.

6 in total

1. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.

Authors: J B Jonas; R F Degenring; I Kreissig; T Friedemann; I Akkoyun
Journal: Eye (Lond) Date: 2005-02 Impact factor: 3.775

2. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

Authors: Careen Lowder; Rubens Belfort; Sue Lightman; C Stephen Foster; Michael R Robinson; Rhett M Schiffman; Xiao-Yan Li; Harry Cui; Scott M Whitcup
Journal: Arch Ophthalmol Date: 2011-01-10

3. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

Authors: J B Jonas; I Akkoyun; I Kreissig; R F Degenring
Journal: Br J Ophthalmol Date: 2005-03 Impact factor: 4.638

4. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.

Authors: David S Boyer; David Faber; Sunil Gupta; Sunil S Patel; Homayoun Tabandeh; Xiao-Yan Li; Charlie C Liu; Jean Lou; Scott M Whitcup
Journal: Retina Date: 2011-05 Impact factor: 4.256

5. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.

Authors: Joan-En Chang-Lin; Mayssa Attar; Andrew A Acheampong; Michael R Robinson; Scott M Whitcup; Baruch D Kuppermann; Devin Welty
Journal: Invest Ophthalmol Vis Sci Date: 2011-01-05 Impact factor: 4.799

6. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Authors: Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young-Hee Yoon; Marie-Louise Jacques; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup
Journal: Ophthalmology Date: 2010-04-24 Impact factor: 12.079

6 in total

4 in total

Steroid implant in anterior chamber of an aphakic vitrectomized eye.

1. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.

2. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

3. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

4. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.

5. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.

6. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

1. New Drugs and New Posterior Delivery Methods in CME.

2. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).

3. Anterior migration of dexamethasone implant in a pseudophakic patient with intact posterior capsule.

4. Corneal graft failure due to migration of Ozurdex™ implant into the anterior chamber.